Gregg Goldfarb
January 22, 2024 | Daily Business Review
Too Good to Be True? Ozempic Lawsuit Moves Forward as Gastrointestinal Issues SurfaceOzempic isn't without side effects, however, and several patients who have experienced severe complications from the drug are now suing Novo Nordisk and Eli Lilly on allegations that the pharmaceutical companies misled doctors on the drugs' potential risks.
By Gregg Goldfarb
5 minute read
June 23, 2023 | Daily Business Review
The Massive Stakes of Anthony Valadez's Case Against Johnson & JohnsonThe outcome of a single asbestos case against J&J will influence an $8.9 billion settlement offer that could change mass torts forever.
By Gregg Goldfarb
5 minute read
Trending Stories
- 1NY High Court Returns Fired Priest's Discrimination Claim to State Agency
- 2Digging Deep to Mitigate Risk in Lithium Mine Venture Wins GM Legal Department of the Year Award
- 3Reminder: Court Rules and Statutes Apply to Pendente Lite Custody Decisions
- 4Consumer Cleared to Proceed With Claims Against CVS 'Non-Drowsy' Medication, Judge Says
- 5Ex-Schnader Partner Nears Settlement in Misappropriated Comp Class Action
More from ALM
- Legal Speak at General Counsel Conference East 2024: Match Group's Katie Dugan & Herrick's Carol Goodman 1 minute read
- Legal Speak at General Counsel Conference East 2024: Eric Wall, Executive VP, Syllo 1 minute read
- Legal Speak at General Counsel Conference East 2024: Virginia Griffith, Director of Business Development at OutsideGC 1 minute read